Chapter 22 — Chemical Coordination And Integration

Fig 1 — Educational Diagram: Introduction to Chemical Coordination

Definition: Chemical coordination is the regulation and integration of physiological activities in multicellular organisms by chemical messengers called hormones. Hormones are secreted by endocrine glands into the blood and act on specific target cells to maintain homeostasis, growth, reproduction and adaptive responses.

Key features of hormones

• Produced in specific endocrine glands (e.g., pancreas, thyroid, adrenal, pituitary).
• Released into blood (no ducts) and transported to distant targets; some are paracrine or autocrine.
• Act at very low concentrations but produce large effects (high potency and amplification).
• Action is specific because target cells have specific receptors (membrane or intracellular).
• Effects may be rapid (seconds to minutes) or slow (hours to days) depending on chemical nature and mechanism.

Types of chemical messengers

• Peptide/protein hormones (insulin, ADH, oxytocin): water-soluble, bind to cell-surface receptors, use second messengers (e.g., cAMP).
• Steroid hormones (cortisol, estrogen): lipid-soluble, diffuse across membranes, bind intracellular receptors to regulate gene transcription.
• Amino-acid derived hormones (thyroxine, adrenaline): thyroxine acts intracellularly; adrenaline acts on surface receptors.

Mechanisms of hormone action (overview)

• Peptide hormone pathway: hormone binds receptor → G-protein activation (in many cases) → adenylate cyclase activation → ATP → cAMP (second messenger) → protein kinase activation → altered enzyme activity and cell response. cAMP is degraded by phosphodiesterase to AMP.
• Steroid hormone pathway: steroid diffuses into cell → binds intracellular receptor → hormone–receptor complex acts as transcription factor → alters gene transcription → changes in protein synthesis and long-term effects.

Regulation: feedback control

• Negative feedback is most common: the hormone effect or the end-product inhibits further secretion (e.g., high blood thyroxine inhibits TSH release from pituitary).
• Positive feedback occurs in special cases (e.g., oxytocin during labour — uterine contraction increases oxytocin release until delivery).

Neuroendocrine integration

Hypothalamus links nervous and endocrine systems. It secretes releasing/inhibiting hormones to control anterior pituitary, and produces neurohormones (ADH, oxytocin) released by posterior pituitary.

Comparison with nervous coordination (brief)

• Nervous: fast, short-lived, electrical + chemical synapses, localized action.
• Endocrine: slower, longer-lasting, chemical by blood, widespread effects.

Importance — Chemical coordination maintains internal constancy: blood glucose (insulin/glucagon), water balance (ADH), metabolic rate (thyroxine), fight-or-flight (adrenaline), growth (growth hormone), reproduction (sex hormones), circadian rhythms (melatonin).

Tip for study: Learn representative hormones (source, target, major effect) and draw simple feedback loops — they appear frequently in exams.

Fig 2 — Educational Diagram: Introduction to Chemical Coordination and Integration

C hemical coordination and integration is the process by which hormones (chemical messengers) produced by endocrine glands regulate physiological activities and maintain homeostasis. Unlike neural coordination, which is rapid and short-lived, chemical coordination is generally slower and long-lasting and coordinates activities that require prolonged regulation (growth, metabolism, reproduction, water balance, etc.).

Key components

• Hormones: Organic substances secreted by endocrine cells directly into the blood. They act on specific target cells that have receptors for them.
• Endocrine glands: Pituitary, thyroid, parathyroid, adrenal, pancreas (islets), pineal, gonads (testes/ovaries), hypothalamus (neuroendocrine), etc.
• Target cells and receptors: Hormones bind to specific receptors (membrane-bound for water-soluble hormones; intracellular for lipid-soluble hormones) to elicit responses.

Mechanisms of action

• Water-soluble hormones (peptides, catecholamines): Cannot cross the plasma membrane. Bind to receptors on the cell surface and use second messengers (e.g., cAMP, IP3/Ca2+) to change cell activity quickly.
• Lipid-soluble hormones (steroid hormones, thyroid hormones): Cross the membrane, bind to intracellular receptors, and directly influence gene transcription—slower onset but longer-lasting effects.

Control and integration

• Feedback regulation: Most endocrine pathways are controlled by negative feedback (e.g., high blood hormone level inhibits its further release). Positive feedback occurs in special cases (e.g., oxytocin during childbirth).
• Neuroendocrine integration: The hypothalamus links the nervous and endocrine systems. It secretes releasing/inhibiting hormones that regulate pituitary secretion; the posterior pituitary releases neurohormones like ADH and oxytocin produced in the hypothalamus.

Important properties of hormones

• Specificity (act only where receptors are present)
• Potency (effective at low concentrations)
• Half-life and clearance (determines duration of action)
• Pulsatile and rhythmic secretion (circadian, ultradian)

Why it matters (integration)

C hemical coordination allows organisms to integrate processes across tissues and time — for example, coordinating metabolism and growth during development, responding to stress, regulating water/electrolyte balance, and managing reproduction. Interaction with the nervous system provides both rapid responses (neural) and sustained regulation (endocrine) to maintain internal stability.

Fig 3 — Educational Diagram: Chemical Nature of Hormones

Definition: Hormones are chemical messengers secreted by endocrine glands into the blood that regulate physiology and behaviour. Their chemical nature determines solubility, mode of transport, receptor location and mechanism of action.

Chemical classification:

• Peptides and proteins: Chains of amino acids (small peptides to large proteins). Water-soluble; circulate free in plasma. Examples: insulin, glucagon, ADH, oxytocin, growth hormone.
• Glycoproteins: Protein hormones with carbohydrate side chains. Water-soluble. Examples: TSH, FSH, LH.
• Amino acid derivatives (amines): Modified single amino acids (often from tyrosine). May be water-soluble or lipid-soluble. Examples: adrenaline (epinephrine), noradrenaline, dopamine, thyroxine (T4) and triiodothyronine (T3).
• Steroid hormones: Lipid-soluble molecules derived from cholesterol. Bind carrier proteins in blood. Examples: cortisol, aldosterone, testosterone, oestrogens, progesterone.
• Eicosanoids (local hormones): Lipid-derived (from arachidonic acid). Act near production site. Examples: prostaglandins, leukotrienes.

Key physicochemical properties and consequences:

• Solubility: Water-soluble hormones (peptides, many amines) are not membrane-permeable and bind to cell-surface receptors; lipid-soluble hormones (steroids, thyroid hormones) cross membranes and bind intracellular receptors.
• Transport in blood: Water-soluble hormones travel freely; lipid-soluble hormones travel bound to plasma carrier proteins (prolongs half-life).
• Receptor location and action:
  • Membrane receptors → second-messenger cascades (fast, reversible effects).
  • Intracellular receptors → alter gene transcription (slower, longer-lasting effects).
• Specificity and affinity: Small changes in hormone or receptor structure change binding (high potency at low concentrations).

Common biochemical signalling mechanisms (conceptual steps):

• Water-soluble hormone binds receptor → activates G-protein → activates adenylate cyclase → ATP converted to cyclic AMP (cAMP) → cAMP activates protein kinase A → phosphorylation of target proteins → cellular response.
• Alternatively, receptor activation can stimulate phospholipase C → PIP2 cleavage into IP3 (releases Ca2+ from ER) and DAG (activates protein kinase C) → response.
• Lipid-soluble hormones diffuse into cell, bind cytosolic or nuclear receptor → hormone–receptor complex binds DNA response elements → regulates transcription of target genes.

Examples in physiology and medicine: Insulin (peptide) controls blood glucose; deficiency causes diabetes mellitus. Cortisol (steroid) mediates long-term stress responses; excess causes Cushing's syndrome. Adrenaline (amine) produces rapid fight-or-flight responses. Thyroid hormones (iodinated tyrosine derivatives) regulate basal metabolic rate; deficiency causes hypothyroidism. Prostaglandins mediate inflammation and are targets of NSAIDs (aspirin).

Important practical notes for students: Understand one clear representative mechanism for each chemical class (e.g., insulin → receptor tyrosine kinase and GLUT translocation; adrenaline → G-protein → cAMP; cortisol → intracellular receptor/transcription). Remember solubility ↔ receptor location ↔ transport mode as a mental triad.

Fig 4 — Educational Diagram: Endocrine System: General Features

Definition and scope
The endocrine system is a collection of glands and hormone-producing cells that secrete chemical messengers (hormones) directly into the blood to regulate physiological processes and maintain homeostasis. Endocrine signalling works alongside the nervous system to coordinate body functions over varying time scales.

Endocrine vs exocrine
Endocrine glands release hormones into the bloodstream (e.g., thyroid, adrenal, pituitary). Exocrine glands release their products into ducts (e.g., salivary, pancreatic exocrine part).

Major endocrine glands
Hypothalamus (neuroendocrine), pituitary (anterior & posterior), thyroid, parathyroids, adrenal cortex & medulla, pancreas (islets), gonads (ovaries/testes), pineal, and many other tissues with endocrine cells.

Chemical nature of hormones
Hormones are chemically diverse: peptides/proteins (insulin, glucagon), amino-acid derivatives (thyroxine, adrenaline), and steroids (cortisol, sex hormones). Chemical type determines solubility, transport, receptor location and mechanism of action.

Classification by action/locality
Endocrine (distant targets via blood), paracrine (neighbouring cells), autocrine (same cell), and intracrine (act within same cell). Examples: prostaglandins (local hormones), cytokines (paracrine/autocrine).

Characteristics of hormones

• Effective at low concentrations (nano- to pico-molar).
• Specificity: hormones act on target cells that have appropriate receptors.
• Reversible binding to receptors; full/partial agonists and antagonists exist.
• Short or long half-lives determined by chemical nature and plasma protein binding.
• Secretion is regulated (neural, humoral or hormonal control).

Mechanisms of hormone action
Two broad pathways based on solubility:

• Water-soluble hormones (peptides/amines): bind to specific cell-surface receptors → activate second-messenger systems (cAMP, IP3/DAG, Ca2+, tyrosine kinase pathways) → rapid effects on enzymes, ion channels, cellular metabolism.
• Lipid-soluble hormones (steroids, thyroid hormones): cross cell membrane → bind intracellular receptors (cytosolic or nuclear) → hormone–receptor complex acts as transcription factor altering gene expression → slower onset, longer-lasting effects.

Receptor binding and dose-response
Response depends on hormone concentration, receptor number and affinity. Receptor occupancy theory and saturation explain why increasing hormone above a certain level does not increase response (receptors become saturated).

Regulation: feedback control
Most endocrine systems are regulated by negative feedback: the hormone’s effect or the level of the variable being controlled suppresses further hormone release (e.g., hypothalamus–pituitary–thyroid axis: TRH → TSH → T3/T4; high T3/T4 inhibit TRH/TSH). Positive feedback exists but is less common (e.g., oxytocin during childbirth enhances contractions → more oxytocin).

Patterns of secretion
Hormones can be secreted continuously, episodically (pulsatile), or with circadian/diurnal rhythms (e.g., cortisol peaks in early morning; melatonin increases at night). Pulsatility prevents receptor desensitisation and maintains responsiveness.

Interactions among hormones
Synergism (combined effect > sum of individual effects; e.g., epinephrine + glucagon on glycogenolysis), antagonism (opposite effects; e.g., insulin vs glucagon), and permissiveness (one hormone enhances target tissue responsiveness to another; e.g., thyroid hormones increase β-adrenergic receptor expression enhancing epinephrine effects).

Transport and half-life
Water-soluble hormones travel freely in plasma and are rapidly cleared. Lipid-soluble hormones bind plasma carrier proteins (e.g., thyroxine-binding globulin), prolonging half-life. Half-life (t1/2) affects duration of action.

Neuroendocrine integration
Hypothalamus links nervous inputs to endocrine outputs via releasing/inhibiting hormones (to anterior pituitary) and by direct neurosecretion from posterior pituitary (oxytocin, ADH). This enables rapid environmental/physiological responses.

Physiological and clinical relevance
Endocrine dysfunction causes disease: diabetes mellitus (insulin deficiency/resistance), hypothyroidism/hyperthyroidism, Cushing’s syndrome (excess cortisol), Addison’s disease (cortisol deficiency), growth disorders (GH imbalance). Understanding general features helps diagnose and treat these conditions.

Summary
The endocrine system uses chemical messengers with high specificity and potent effects to regulate body functions. Hormone chemistry, receptor location, feedback control, secretion patterns and hormone interactions together determine physiological outcomes.

Fig 5 — Educational Diagram: Hypothalamus and Pituitary Gland

Overview
The hypothalamus and pituitary gland form the central control centre for endocrine regulation. The hypothalamus (part of the diencephalon) integrates neural and endocrine signals and controls the pituitary — the master gland — which in turn regulates many peripheral endocrine glands.

Anatomy & histology (brief)

• Hypothalamus: located below the thalamus; contains several nuclei (e.g., supraoptic, paraventricular, arcuate) with neurosecretory neurons.
• Pituitary (hypophysis): sits in the sella turcica; has two distinct parts:
  • Anterior pituitary (adenohypophysis) — glandular tissue; receives hypothalamic releasing/inhibiting hormones via the hypothalamo–hypophyseal portal system.
  • Posterior pituitary (neurohypophysis) — neural tissue; stores and releases neurohormones produced in hypothalamic nuclei (supraoptic & paraventricular).

Major hormones and control

• Hypothalamic releasing/inhibiting hormones: TRH, CRH, GnRH, GHRH, somatostatin (GHIH), dopamine (PIH).
• Anterior pituitary hormones: Growth hormone (GH), Thyroid-stimulating hormone (TSH), Adrenocorticotrophic hormone (ACTH), Follicle-stimulating hormone (FSH), Luteinizing hormone (LH), Prolactin (PRL).
• Posterior pituitary hormones: Antidiuretic hormone (ADH, vasopressin) and Oxytocin (produced in hypothalamus, released from posterior pituitary).

Mechanisms of action and integration
- Hypothalamic neurosecretory cells synthesize releasing/inhibiting factors that reach the anterior pituitary through the portal blood vessels, finely regulating pituitary secretion.
- Posterior pituitary hormones are synthesized in hypothalamic neurons, transported along axons and exocytosed into blood from nerve terminals in the neurohypophysis.
- Most axes work by a classical three‑tier pathway: Hypothalamus → Pituitary → Peripheral gland (e.g., CRH → ACTH → Cortisol). Peripheral hormones exert negative feedback on both pituitary and hypothalamus to maintain homeostasis.

Physiological roles

• GH: growth, metabolism (stimulates IGF-1 from liver).
• TSH: stimulates thyroid hormone synthesis (metabolic rate).
• ACTH: stimulates cortisol release (stress response, metabolism).
• FSH/LH: gametogenesis and sex steroid production.
• Prolactin: milk production; inhibited by hypothalamic dopamine.
• ADH: water reabsorption in kidneys (vasopressin); controls plasma osmolality and blood pressure.
• Oxytocin: uterine contraction, milk ejection, social/behavioral effects.

Regulation & feedback
Negative feedback is the dominant control: increased peripheral hormone levels suppress hypothalamic releasing factors and pituitary output. Pulsatile and circadian secretion patterns (e.g., cortisol peaks in early morning) are important for normal function.

Clinical correlations (common disorders)

• Pituitary adenomas: excess hormone secretion (e.g., prolactinoma → galactorrhoea, amenorrhea) or mass effect (bitemporal hemianopia from optic chiasm compression).
• GH disorders: pituitary gigantism (children), acromegaly (adults), GH deficiency → short stature (children).
• Diabetes insipidus: ADH deficiency → polyuria, polydipsia; treated with desmopressin (DDAVP).
• Syndrome of inappropriate ADH (SIADH): water retention and hyponatraemia.
• Cushing's disease: ACTH‑secreting pituitary adenoma → hypercortisolism.

Investigations & tests
Hormone assays (serum/plasma), stimulation tests (e.g., insulin tolerance test for GH/ACTH), suppression tests (dexamethasone suppression for Cushing's), MRI for pituitary imaging.

Summary
The hypothalamus and pituitary form a tightly integrated neuroendocrine unit controlling growth, metabolism, reproduction, stress and fluid balance. Understanding their anatomy, hormone axes and feedback loops is key to diagnosing and managing many endocrine disorders.

Fig 6 — Educational Diagram: Mechanism of Hormone Action

Overview
Hormones are chemical messengers secreted by endocrine glands that regulate target cells/organs. The mechanism of hormone action describes how a hormone communicates its signal to alter cell physiology: from hormone release, to receptor binding, signal transduction, amplification, cellular response and termination.

Classification by solubility and receptor location

• Water‑soluble hormones (peptides, many amines like adrenaline): cannot cross the plasma membrane → bind to cell‑surface receptors (GPCRs, receptor tyrosine kinases, ion‑channel linked receptors) → use second messengers.
• Lipid‑soluble hormones (steroids, thyroid hormones): diffuse through membrane (or use transport proteins in blood), bind to intracellular receptors (cytoplasm or nucleus) → regulate gene transcription (direct gene activation).

General sequence of events

1. Recognition: Hormone (ligand) binds a specific receptor on/in the target cell.
2. Receptor activation: Conformational change activates associated proteins (G‑proteins, kinases, etc.).
3. Signal transduction & amplification: Activated receptors generate second messengers (cAMP, IP3, DAG, cGMP, Ca2+) or activate phosphorylation cascades. One hormone‑receptor interaction can activate many second‑messenger molecules → amplification.
4. Cellular response: Rapid changes (enzyme activity, ion channel opening) or slower changes (altered gene transcription and protein synthesis).
5. Termination/desensitization: Hormone degradation, receptor internalization, phosphodiesterases, protein phosphatases return cell to basal state.

Key signalling pathways (concise)

• GPCR → cAMP pathway: Hormone binds GPCR → Gs protein activates adenylyl cyclase → ATP converted to cAMP → cAMP activates protein kinase A (PKA) → phosphorylation of target proteins.
• GPCR → IP3/DAG pathway: Hormone → Gq protein → phospholipase C (PLC) cleaves PIP2 → IP3 (releases Ca2+ from ER) + DAG (activates PKC) → Ca2+/PKC regulate targets.
• Enzyme‑linked receptors (RTKs, e.g., insulin receptor): Ligand binding causes receptor dimerization and autophosphorylation on tyrosine residues → recruitment of adaptor proteins → kinase cascades (e.g., MAPK) and metabolic effects (e.g., GLUT4 translocation).
• Intracellular receptors (steroid/thyroid): Hormone diffuses into cell → binds cytosolic/nuclear receptor → receptor‑hormone complex binds hormone response elements on DNA → alters transcription → new protein synthesis (effects usually slower, longer lasting).
• Nitric oxide (paracrine): Agonist (e.g., acetylcholine) stimulates NO synthase → NO diffuses to smooth muscle → activates guanylyl cyclase → GTP → cGMP → relaxation (vasodilation).

Specificity and sensitivity
Specificity arises from receptor expression and receptor‑ligand affinity. Sensitivity is modulated by receptor number, second‑messenger amplification and cross‑talk between pathways. Receptor occupancy follows basic ligand‑binding kinetics (see formulas).

Termination mechanisms
Examples: hormone clearance from blood (liver, kidney), receptor internalization or down‑regulation, degradation of second messengers (phosphodiesterases degrade cAMP/cGMP), dephosphorylation by phosphatases.

Clinical/physiological relevance
Disorders in any step (insulin receptor defects in diabetes, thyroid hormone deficiencies, abnormal GPCR signalling) produce characteristic disease states. Many drugs target receptors or signalling enzymes (e.g., β‑blockers block adrenaline GPCRs; phosphodiesterase inhibitors raise cAMP/cGMP).

Fig 7 — Educational Diagram: Hypothalamus and Pituitary

Overview

The hypothalamus and pituitary together form the major control centre of the endocrine system. The hypothalamus (part of the diencephalon) integrates neural and endocrine signals and regulates homeostasis. It controls the pituitary gland (hypophysis), which secretes hormones that act on many peripheral endocrine glands and tissues.

Structure

• Hypothalamus: contains neurosecretory cells grouped in nuclei (e.g., supraoptic and paraventricular nuclei). It produces releasing and inhibiting hormones (e.g., TRH, CRH, GnRH, GHRH, somatostatin/GHIH, dopamine) and the neurohormones ADH (vasopressin) and oxytocin.
• Pituitary gland: lies in the sella turcica and has two main parts: Anterior pituitary (adenohypophysis)—glandular tissue derived from Rathke's pouch; and Posterior pituitary (neurohypophysis)—neural tissue continuous with the hypothalamus.

Functional connections

• Hypothalamo‑hypophyseal portal system: short blood vessels that carry hypothalamic releasing/inhibiting hormones to the anterior pituitary, regulating its hormone secretion.
• Hypothalamo‑hypophyseal tract: axons from supraoptic and paraventricular nuclei transport ADH and oxytocin to the posterior pituitary for storage and release.

Major hormones and main actions

• Anterior pituitary: growth hormone (GH) — growth and metabolism; thyroid‑stimulating hormone (TSH) — stimulates thyroid; adrenocorticotropic hormone (ACTH) — stimulates adrenal cortex to produce cortisol; follicle‑stimulating hormone (FSH) and luteinizing hormone (LH) — gonadal function; prolactin (PRL) — milk production; melanocyte‑stimulating hormone (MSH) — pigmentation (minor in humans).
• Posterior pituitary: vasopressin/ADH — water reabsorption in kidney (raises blood pressure, reduces urine volume); oxytocin — uterine contraction and milk ejection.

Regulation and feedback

The common motif is: Hypothalamus → (releasing hormone) → Anterior pituitary → (tropic hormone) → Peripheral endocrine gland → Hormone → Target tissues. Peripheral hormones usually exert negative feedback on both pituitary and hypothalamus to maintain homeostasis (e.g., high thyroid hormones suppress TRH and TSH). Some hypothalamic hormones are inhibitory (e.g., dopamine inhibits prolactin; somatostatin inhibits GH).

Physiological characteristics

• Hormone secretion can be pulsatile and follow circadian rhythms (e.g., GH secreted in pulses during deep sleep; ACTH and cortisol peak in early morning).
• Posterior pituitary hormones are synthesized in hypothalamic neurons and stored in nerve endings in the posterior lobe.

Disorders — brief

• ADH deficiency → diabetes insipidus: polyuria (large volumes of dilute urine) and polydipsia; treated with desmopressin (synthetic ADH).
• ADH excess → SIADH: water retention, hyponatraemia.
• GH excess: gigantism (before epiphyseal closure) or acromegaly (after closure). GH deficiency → pituitary dwarfism.
• Prolactinoma (pituitary tumour) → galactorrhea, amenorrhoea; treated with dopamine agonists.
• ACTH‑secreting tumours → Cushing's disease (excess cortisol).

Clinical and practical notes

• Water‑deprivation test helps differentiate central diabetes insipidus from nephrogenic DI.
• Oxytocin is used clinically to induce or augment labour and to prevent postpartum haemorrhage.
• Hormone replacement or suppression therapy is used depending on deficiency or excess (e.g., levothyroxine for hypothyroidism; transsphenoidal surgery for pituitary tumours).

Fig 8 — Educational Diagram: Thyroid and Parathyroid Glands

Thyroid Gland

Location & structure: A butterfly-shaped endocrine gland in the neck, anterior to the trachea. Microscopic units are follicles lined by follicular epithelial cells filled with colloid (thyroglobulin). Parafollicular (C) cells lie between follicles.

Major hormones:

• Thyroxine (T4) — main secreted form (prohormone).
• Triiodothyronine (T3) — active form (mostly produced by peripheral deiodination of T4).
• Calcitonin — from C cells; lowers blood calcium slightly by inhibiting bone resorption.

Synthesis of T3/T4 (stepwise):

• Iodide uptake (iodide trapping) into follicular cell from blood via Na+/I- symporter.
• Oxidation of I- to I0 and iodination of tyrosyl residues on thyroglobulin in the colloid → mono- and di-iodotyrosine (MIT, DIT).
• Coupling reactions on thyroglobulin: MIT + DIT → T3; DIT + DIT → T4.
• Endocytosis of iodinated thyroglobulin, proteolysis in lysosomes → release of T3 and T4 into blood.
• Transport: >99% of T3/T4 bind plasma proteins (thyroxine-binding globulin, albumin); free fractions (fT3/fT4) are biologically active.

Physiological actions:

• Increase basal metabolic rate (↑O2 consumption, ↑heat production) by stimulating mitochondrial activity and gene expression of metabolic enzymes.
• Promote growth and neural development (crucial in fetal and neonatal life).
• ↑Heart rate and contractility, ↑lipid and carbohydrate metabolism, affect protein turnover.

Regulation (hypothalamic–pituitary–thyroid axis):

• Hypothalamus secretes TRH → stimulates anterior pituitary to secrete TSH → stimulates thyroid to produce T3/T4.
• Negative feedback: ↑free T3/T4 → ↓TSH and ↓TRH. TSH also stimulates thyroid growth (excess TSH → goitre).

Disorders (common features):

• Hypothyroidism: fatigue, cold intolerance, weight gain, bradycardia. In infants → cretinism (mental retardation, stunted growth). Adults → myxedema.
• Hyperthyroidism: weight loss, heat intolerance, tremor, tachycardia; Graves' disease: autoantibodies stimulating TSH receptor → goitre, exophthalmos.
• Goitre: enlargement of thyroid due to iodine deficiency or TSH overstimulation.

Normal lab ranges (approximate): TSH ~ 0.4–4.0 mIU/L; Free T4 ~ 0.8–1.8 ng/dL; Free T3 ~ 2.3–4.2 pg/mL (laboratory-dependent).

Parathyroid Glands

Location & structure: Usually four small glands on the posterior surface of the thyroid. Two main cell types: chief (principal) cells produce parathyroid hormone (PTH); oxyphil cells of unclear endocrine role.

PTH: the principal hormone regulating blood calcium. Secreted in response to low plasma Ca2+ (sensed directly by Ca2+-sensing receptors on chief cells).

Main actions of PTH (net effect: ↑serum Ca2+):

• Bone: stimulates osteoclast activity indirectly (via osteoblast signalling) → bone resorption → release of Ca2+ and PO4 3-.
• Kidney: ↑reabsorption of Ca2+ in distal tubule, ↓reabsorption of phosphate in proximal tubule (phosphaturia), and stimulates 1α-hydroxylase → conversion of 25(OH)D to active 1,25(OH)2D (calcitriol).
• Intestine (via calcitriol): ↑absorption of Ca2+ and phosphate.

Regulation: PTH secretion is tightly and inversely related to serum ionized Ca2+. Small decreases in Ca2+ cause marked increases in PTH. Rising Ca2+ suppresses PTH secretion.

Disorders:

• Hyperparathyroidism: excess PTH → hypercalcemia → kidney stones, bone pain/osteoporosis, polyuria, neuropsychiatric symptoms.
• Hypoparathyroidism: low PTH → hypocalcemia → tetany, muscle cramps, paresthesias; often follows thyroid/parathyroid surgery.

Interaction between thyroid and parathyroid: calcitonin (thyroid) and PTH (parathyroid) have opposite short-term effects on bone Ca2+ handling; long-term calcium homeostasis is dominated by PTH and vitamin D.

Clinical relevance and screening: newborn TSH/T4 screening prevents cretinism; iodized salt prevents endemic goitre; levothyroxine (synthetic T4) treats hypothyroidism; antithyroid drugs, radioactive iodine, or surgery treat hyperthyroidism. PTH and serum Ca2+/phosphate measurements guide diagnosis of parathyroid disorders.

Fig 9 — Educational Diagram: Adrenal Glands

Adrenal Glands

The adrenal (suprarenal) glands are paired endocrine glands located on the superior pole of each kidney. Each gland has two structurally and functionally distinct parts: the outer adrenal cortex and the inner adrenal medulla. They secrete steroid and catecholamine hormones that regulate metabolism, salt–water balance, stress responses and some secondary sexual characteristics.

Structure & Zones

• Adrenal cortex (derived from mesoderm) — three concentric zones:
  • Zona glomerulosa: produces mineralocorticoids (mainly aldosterone).
  • Zona fasciculata: produces glucocorticoids (mainly cortisol).
  • Zona reticularis: produces adrenal androgens (e.g., DHEA).
• Adrenal medulla (derived from neural crest) — chromaffin cells that secrete catecholamines: epinephrine (adrenaline) and norepinephrine (noradrenaline).

Major Hormones & Functions

• Aldosterone (mineralocorticoid): increases Na+ reabsorption and K+ secretion in renal distal tubules and collecting ducts → increases blood volume and blood pressure. Stimulated by angiotensin II, high plasma K+, low Na+.
• Cortisol (glucocorticoid): increases gluconeogenesis, mobilizes amino acids and fatty acids, has anti-inflammatory and immunosuppressive effects, helps body adapt to stress. Secretion controlled by hypothalamic CRH → anterior pituitary ACTH → adrenal cortex (negative feedback by cortisol).
• Adrenal androgens (e.g., DHEA): weak androgens converted to stronger androgens/estrogens in peripheral tissues; more important in females for libido and pubic/axillary hair development.
• Adrenaline and Noradrenaline: increase heart rate, cardiac output, bronchial dilation, glycogenolysis, lipolysis, and divert blood to muscles (fight-or-flight). Medullary secretion is under sympathetic nervous system control (splanchnic nerves) and rapid (seconds).

Regulation

• Renin–Angiotensin–Aldosterone System (RAAS): decreased renal perfusion → renin release → converts angiotensinogen to angiotensin I → ACE converts angiotensin I to angiotensin II → stimulates aldosterone release.
• HPA axis: stress or diurnal rhythm → hypothalamic CRH → pituitary ACTH → cortisol secretion; cortisol exerts negative feedback on CRH and ACTH.
• Sympathetic activation: preganglionic fibres stimulate chromaffin cells to release catecholamines immediately during stress.

Clinical Correlates

• Addison's disease (primary adrenal insufficiency): low cortisol and aldosterone → fatigue, hypotension, hyperkalemia, hyponatremia, hyperpigmentation (due to raised ACTH).
• Cushing's syndrome: chronic high cortisol (from pituitary ACTH excess or adrenal tumor) → central obesity, moon face, muscle wasting, hyperglycemia, immunosuppression.
• Conn's syndrome (primary hyperaldosteronism): aldosterone-secreting tumor → hypertension, hypokalemia.
• Pheochromocytoma: catecholamine-secreting tumor of medulla → episodic hypertension, palpitations, sweating, headache.

Takeaway: Adrenal glands integrate short-term (catecholamines) and long-term (steroids) responses to maintain homeostasis under normal and stressful conditions.

Fig 10 — Educational Diagram: Adrenal Gland

Definition and location: The adrenal (suprarenal) glands are paired endocrine glands located on the superior pole of each kidney. Each gland has two structurally and functionally distinct parts: an outer cortex and an inner medulla.

Structure and embryonic origin: The adrenal cortex is derived from mesoderm and is divided into three zones from outside to inside: zona glomerulosa, zona fasciculata, and zona reticularis. The adrenal medulla is derived from neural crest (ectoderm) and consists of chromaffin cells.

Hormones produced and their actions:

• Cortex (steroid hormones, lipid-soluble):
• Zona glomerulosa: mineralocorticoids (mainly aldosterone) — regulate sodium and potassium balance, blood volume and blood pressure by increasing renal Na+ reabsorption and K+ secretion.
• Zona fasciculata: glucocorticoids (mainly cortisol in humans) — regulate carbohydrate, protein and fat metabolism, increase blood glucose (gluconeogenesis), have anti-inflammatory and immunosuppressive effects, and help in stress adaptation.
• Zona reticularis: adrenal androgens (eg, DHEA) — weak androgens that can be converted to stronger sex steroids in peripheral tissues.
• Medulla (catecholamines, water-soluble):
• Chromaffin cells secrete epinephrine (adrenaline) and norepinephrine (noradrenaline) — responsible for the rapid fight-or-flight response: increase heart rate, contractility, bronchodilation, glycogenolysis, lipolysis, and vasoconstriction in some vascular beds.

Regulation:

• Cortisol secretion is primarily regulated by the hypothalamic-pituitary-adrenal (HPA) axis: hypothalamus releases CRH (corticotropin-releasing hormone) → anterior pituitary releases ACTH → ACTH stimulates cortisol secretion from zona fasciculata. Cortisol exerts negative feedback on CRH and ACTH.
• Aldosterone is mainly regulated by the renin-angiotensin-aldosterone system (RAAS) and by plasma K+; ACTH has a minor stimulatory role.
• Medullary catecholamines are released in response to sympathetic preganglionic stimulation (acetylcholine) and circulating stress signals.

Physiological roles and importance:

• Stress response: cortisol and catecholamines enable the body to respond to physical and emotional stress.
• Metabolic regulation: cortisol promotes gluconeogenesis, protein catabolism and lipolysis to increase blood glucose and fuel availability.
• Fluid-electrolyte balance and blood pressure: aldosterone conserves sodium and water, increasing blood volume and pressure.
• Acute cardiovascular adjustments: epinephrine increases cardiac output and redistributes blood flow.

Common disorders:

• Cushing's syndrome (excess cortisol): features include central obesity, moon face, buffalo hump, muscle wasting, hyperglycemia, hypertension.
• Addison's disease (primary adrenal insufficiency): deficiency of cortisol and aldosterone; symptoms include fatigue, weight loss, hypotension, hyperpigmentation (from high ACTH), hyponatremia, hyperkalemia.
• Conn's syndrome (primary hyperaldosteronism): excess aldosterone → hypertension, hypokalemia, muscle weakness.
• Pheochromocytoma: catecholamine-secreting tumor of medulla → episodic hypertension, palpitations, sweating, headaches.

Clinical notes: Measurement of serum cortisol, plasma ACTH, renin activity, aldosterone levels and urinary catecholamines/metanephrines are used to diagnose adrenal disorders. Imaging (CT/MRI) locates tumors or hyperplasia. Treatment may include hormone replacement, surgery, or drugs that block hormone synthesis.

Fig 11 — Educational Diagram: Pancreas and Regulation of Blood Glucose

Overview

The pancreas is a mixed gland with exocrine (digestive enzymes) and endocrine components. The endocrine portion consists of pancreatic islets (islets of Langerhans) that regulate blood glucose by secreting hormones—primarily insulin from beta (β) cells and glucagon from alpha (α) cells.

Structure and cells

• Islets contain β cells (insulin), α cells (glucagon), and δ cells (somatostatin).
• β cells sense blood glucose and secrete insulin; α cells secrete glucagon during low glucose.

Insulin: synthesis and action

Insulin is synthesized as preproinsulin → proinsulin → insulin + C‑peptide. Mechanism of glucose‑stimulated insulin release in β cells: glucose uptake → phosphorylation by glucokinase → increased ATP → closure of K+ATP channels → membrane depolarization → opening of voltage‑gated Ca2+ channels → Ca2+ influx → exocytosis of insulin vesicles.

Major actions of insulin (anabolic hormone):

• Muscle: increases glucose uptake (GLUT4 translocation), glycogen synthesis, protein synthesis.
• Liver: stimulates glycogenesis, inhibits glycogenolysis and gluconeogenesis; promotes lipogenesis.
• Adipose tissue: increases glucose uptake and triglyceride synthesis; inhibits lipolysis.

Glucagon: synthesis and action

Glucagon is secreted by α cells when blood glucose is low. It acts mainly on the liver via a GPCR → adenylate cyclase → ↑cAMP → PKA activation. Effects (catabolic): stimulates glycogenolysis (glycogen → glucose), stimulates gluconeogenesis, promotes lipolysis and ketogenesis.

Homeostatic regulation

Blood glucose is maintained by a negative feedback system: rise in blood glucose → ↑insulin, ↓glucagon → storage and utilization of glucose → glucose level falls toward normal. Fall in blood glucose → ↑glucagon, ↓insulin → mobilization of glucose, synthesis of new glucose.

Key metabolic pathways involved

• Glycolysis: glucose → pyruvate (energy production).
• Glycogenesis: glucose → glycogen (storage, promoted by insulin).
• Glycogenolysis: glycogen → glucose-1-phosphate → glucose (mobilization, promoted by glucagon/epinephrine).
• Gluconeogenesis: noncarbohydrates → glucose (promoted by glucagon).

Physiological ranges and clinical points

• Normal fasting blood glucose: about 70–100 mg/dL (3.9–5.6 mmol/L).
• Postprandial (2 h) normal: <140 mg/dL (<7.8 mmol/L).
• Hypoglycemia: <70 mg/dL; symptoms include sweating, tremor, confusion; can result from excess insulin.
• Diabetes mellitus: chronic hyperglycemia. Type 1: autoimmune destruction of β cells → insulin deficiency. Type 2: insulin resistance ± relative insulin deficiency.

Cell signaling highlights

Insulin receptor is a receptor tyrosine kinase that triggers phosphorylation cascades → metabolic and gene regulation effects. Insulin promotes translocation of GLUT4 vesicles to the cell membrane in muscle and adipose tissue, increasing glucose uptake.

Clinical and physiological examples

After a carbohydrate-rich meal, blood glucose rises, triggering insulin release: liver and muscle store glucose as glycogen and adipose stores triglycerides. During fasting or between meals, glucagon maintains blood glucose by glycogenolysis and gluconeogenesis. In prolonged starvation, ketone bodies increase as fat is used for energy.

Summary

Pancreatic hormones insulin and glucagon work antagonistically to maintain blood glucose within a narrow range by balancing uptake, storage, and production of glucose. Disruption leads to hypo- or hyperglycemia and metabolic disease such as diabetes.

Fig 12 — Educational Diagram: Pancreas (Endocrine Function) and Diabetes

Overview

The pancreas has both exocrine and endocrine parts. The endocrine portion consists of the islets of Langerhans — clusters of cells that secrete hormones directly into the blood to regulate blood glucose and metabolism.

Cell types and hormones

• β (beta) cells: secrete insulin — lowers blood glucose by promoting uptake and storage of glucose.
• α (alpha) cells: secrete glucagon — raises blood glucose by stimulating glycogenolysis and gluconeogenesis in the liver.
• δ (delta) cells: secrete somatostatin — inhibits secretion of insulin and glucagon (paracrine regulator).
• PP cells (F cells): secrete pancreatic polypeptide — influences pancreatic secretions and appetite.

Mechanism of insulin secretion (simplified)

When blood glucose rises (e.g., after a meal):

1. Glucose enters β-cells via GLUT transporters and is metabolized to generate ATP.
2. Increased ATP/ADP ratio closes ATP-sensitive K+ channels → membrane depolarization.
3. Voltage-gated Ca2+ channels open → Ca2+ influx triggers exocytosis of insulin-containing vesicles.

Major actions of insulin

• Increases glucose uptake in muscle/adipose (GLUT4 translocation).
• Stimulates glycogenesis (glycogen synthesis) in liver and muscle.
• Promotes glycolysis and lipogenesis; inhibits gluconeogenesis and glycogenolysis.
• Enhances amino acid uptake and protein synthesis; inhibits protein breakdown.

Glucose homeostasis (feedback loop)

Insulin and glucagon act antagonistically to keep blood glucose within a narrow range. After a meal, insulin dominates to store excess glucose. During fasting, glucagon maintains blood glucose by releasing stored glucose and stimulating new glucose production.

Diabetes mellitus — types and causes

• Type 1 diabetes (insulin-dependent): autoimmune destruction of β-cells → absolute insulin deficiency. Common onset in children/young adults. Requires insulin replacement.
• Type 2 diabetes (non–insulin-dependent): insulin resistance in target tissues plus relative insulin deficiency. Strongly associated with obesity, sedentary lifestyle, and genetics. Managed with lifestyle changes, oral drugs, and sometimes insulin.
• Gestational diabetes: glucose intolerance first recognized during pregnancy due to hormonal insulin resistance; usually monitored and managed to protect mother and fetus.
• Other types: genetic defects, pancreatic disease, drug-induced, endocrine disorders.

Clinical features & complications

Common acute symptoms: polyuria (frequent urination), polydipsia (excessive thirst), polyphagia (increased hunger), unexplained weight loss, fatigue, blurred vision. Severe hyperglycemia can cause diabetic ketoacidosis (DKA) in type 1. Long-term complications: microvascular (retinopathy, nephropathy, neuropathy) and macrovascular (cardiovascular disease) damage.

Diagnosis (important CBSE values)

• Fasting plasma glucose: normal 70–100 mg/dL (3.9–5.6 mmol/L). Diabetes if ≥ 126 mg/dL (≥ 7.0 mmol/L).
• 2-hour plasma glucose during 75 g OGTT: diabetes if ≥ 200 mg/dL (≥ 11.1 mmol/L).
• Random plasma glucose ≥ 200 mg/dL (11.1 mmol/L) with symptoms = diabetes.
• HbA1c >= 6.5% indicates diabetes (also used to monitor long-term control).

Management (overview)

• Type 1: insulin therapy (multiple daily injections or pump), carbohydrate counting, regular monitoring.
• Type 2: lifestyle modification (diet, exercise, weight loss), oral antidiabetic drugs (e.g., metformin, sulfonylureas), sometimes insulin or other injectables (GLP-1 analogues, SGLT2 inhibitors).
• Monitoring: self blood glucose testing, HbA1c every few months to assess average control.

Summary (CBSE focus)

Endocrine pancreas (islets of Langerhans) maintains blood glucose via insulin and glucagon. Diabetes is the result of impaired insulin production or action, diagnosed using blood glucose/HbA1c criteria and managed by medicines and lifestyle to prevent complications.

Fig 13 — Educational Diagram: Pineal, Thymus and Other Endocrine Tissues

Overview: Besides the major endocrine glands (pituitary, thyroid, adrenals, pancreas, gonads), several organs/tissues produce hormones that help regulate physiology. Important ones studied in Class 11 are the pineal gland and thymus; other tissues with endocrine functions include the heart, kidney, gastrointestinal tract, adipose tissue, skin, liver and placenta.

Pineal Gland

• Location & structure: Small, cone-shaped endocrine structure in the epithalamus near the midline of the brain.
• Main hormone: Melatonin (derived from tryptophan → serotonin → melatonin).
• Functions:
  • Regulates sleep–wake cycle (circadian rhythm): melatonin is high at night and low in daylight.
  • Influences seasonal reproductive cycles in some animals (photoperiodism).
  • Has antioxidant and modulatory effects on mood and immune function.
• Regulation: Light perceived by retina → signal to suprachiasmatic nucleus (SCN) → pineal via sympathetic pathway; light suppresses melatonin secretion, darkness stimulates it.
• Clinical relevance / examples: Melatonin supplements are used for jet lag and some sleep disorders; altered melatonin patterns are linked with seasonal affective disorder (SAD) and certain sleep problems.

Thymus

• Location & structure: Bilobed organ in the anterior mediastinum, most active in infancy and childhood; involutes after puberty and largely replaced by adipose tissue in adults.
• Hormones: Thymosin, thymopoietin and related peptides.
• Functions:
  • Essential for maturation, differentiation and education of T-lymphocytes (cell-mediated immunity).
  • Helps establish self-tolerance and functional adaptive immune system during early life.
• Clinical relevance: Thymic disorders or early removal can impair T-cell development; thymic involution occurs with age and stress. Thymus abnormalities are associated with immune defects (e.g., DiGeorge syndrome involves thymic hypoplasia).

Other Endocrine Tissues (brief summary by organ)

• Heart — Atria produce atrial natriuretic peptide (ANP): reduces blood volume and blood pressure by promoting natriuresis and inhibiting renin/aldosterone.
• Kidney — Produces erythropoietin (EPO) to stimulate RBC production in response to hypoxia; juxtaglomerular cells secrete renin (start of renin–angiotensin system).
• Gastrointestinal tract — Endocrine cells secrete gastrin, secretin, cholecystokinin (CCK), gastric inhibitory peptide (GIP) etc., which regulate digestion, enzyme secretion and appetite.
• Adipose tissue — Secretes leptin (regulates appetite and energy balance), adiponectin (metabolic effects) and other cytokines.
• Skin — Produces cholecalciferol (vitamin D3) precursor under UV light; converted in liver/kidney to active calcitriol (hormone regulating Ca2+ homeostasis).
• Liver — Produces insulin-like growth factor 1 (IGF-1) in response to growth hormone; modifies many hormones (activation/inactivation).
• Placenta — Endocrine organ in pregnancy secreting hCG, progesterone, estrogens and human placental lactogen (hPL) to maintain pregnancy and fetal development.

Key concepts & integration

• Many tissues have secondary endocrine roles — paracrine or systemic — and interact with classical endocrine axes.
• Homeostasis is often maintained by feedback loops: for example, ANP opposes the renin–angiotensin–aldosterone system (RAAS) to regulate blood pressure.
• Developmental timing matters: thymus active in early life for immune education; pineal melatonin provides time cues for circadian systems.

Quick clinical/real-life notes

• Melatonin supplements: used short-term for jet lag and some insomnia cases.
• Thymic involution: normal with age; premature loss (congenital) causes immune deficiency.
• EPO therapies: used to treat anemia (e.g., in chronic kidney disease), but misuse can appear in sport doping.

Tip for study: Know each tissue: its hormone(s), main physiological role, how secretion is regulated, and one clinical application/implication.

Fig 14 — Educational Diagram: Reproductive Endocrinology

Overview
Reproductive endocrinology studies hormones and endocrine control of sexual development, gametogenesis and reproduction. The central regulatory axis is the hypothalamo–pituitary–gonadal (HPG) axis: hypothalamus (GnRH) → anterior pituitary (FSH, LH) → gonads (testes or ovaries) producing sex steroids (testosterone, oestrogens, progesterone) and gametes.

HPG axis and feedback
Gonadotropin-releasing hormone (GnRH) is secreted in pulses from the hypothalamus. Pulsatile GnRH stimulates release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the anterior pituitary. FSH and LH act on gonads to produce sex steroids and support gametogenesis. Sex steroids exert negative and (in specific phases) positive feedback on hypothalamus and pituitary to regulate the cycle.

Female reproductive endocrinology — ovarian and menstrual cycle
The ovarian cycle has two main phases: follicular (pre-ovulatory) and luteal (post-ovulatory). Key hormonal events across a typical 28-day cycle:

• Early follicular phase: FSH stimulates follicle growth; follicles produce oestradiol (E2).
• Late follicular/midcycle: Rising E2 exerts positive feedback on the hypothalamus/pituitary, causing an LH surge — this LH surge triggers ovulation (release of the oocyte) and completion of meiosis I.
• Luteal phase: The ruptured follicle becomes corpus luteum, which secretes progesterone (and some oestradiol). Progesterone maintains endometrium and exerts negative feedback on GnRH/LH/FSH. If pregnancy does not occur, corpus luteum degenerates → progesterone falls → menstruation.

Pregnancy and placenta
If fertilisation and implantation occur, the trophoblast secretes human chorionic gonadotropin (hCG), which mimics LH and maintains the corpus luteum (maintains progesterone production) until the placenta takes over steroid synthesis. Placental oestrogens and progesterone support pregnancy. hCG is the basis of pregnancy tests.

Male reproductive endocrinology
In males, LH stimulates Leydig cells to produce testosterone; FSH acts on Sertoli cells to support spermatogenesis and produce inhibin. Testosterone (and inhibin) provide negative feedback on hypothalamus and pituitary to regulate GnRH, LH and FSH levels. Continuous (rather than cyclic) hormone levels maintain ongoing spermatogenesis.

Sexual differentiation and puberty
Genetic sex (SRY on Y chromosome) drives testis development; fetal testes produce testosterone and anti-Müllerian hormone (AMH) to promote male internal/external genital differentiation. Puberty begins when increased pulsatile GnRH secretion elevates LH/FSH and sex steroids, producing secondary sexual characteristics and gametogenesis.

Clinical relevance
Knowledge of reproductive endocrinology underlies: oral contraceptives (combined estrogen–progestin pills suppress ovulation by negative feedback), ovulation tests (detect LH surge), fertility treatments (clomiphene, controlled ovarian stimulation, IVF), hormonal contraception (progestin-only methods), and management of disorders such as polycystic ovary syndrome (PCOS), amenorrhea, hypogonadism, and use of GnRH analogs in hormone-dependent cancers.

Key principles to remember

• Pulsatility: GnRH pulse frequency and amplitude determine relative LH and FSH secretion.
• Feedback: Sex steroids usually negative-feedback the axis, but sustained high oestradiol midcycle produces a short positive feedback that causes the LH surge and ovulation.
• Hormone mimicry: hCG mimics LH; many drugs act by agonizing or antagonizing GnRH, LH, FSH, or sex-steroid receptors.

Fig 15 — Educational Diagram: Hormonal Regulation of Growth, Development and Metabolism

Overview: Hormones are chemical messengers produced by endocrine glands (animals) or specific tissues (plants) that regulate growth, development and metabolism. They act at low concentrations, bind to specific receptors and change cellular activities by altering gene expression or enzyme activities. Regulation often occurs through feedback loops to maintain homeostasis.

Mechanisms of action:

• Lipid‑soluble hormones (steroid hormones, thyroid hormones): diffuse across cell membranes, bind intracellular receptors, and directly modulate gene transcription (slow but long‑lasting effects).
• Water‑soluble hormones (peptides, catecholamines): bind cell‑surface receptors, activate second‑messenger cascades (cAMP, IP3/Ca2+, kinase cascades) producing rapid but often short‑lived responses.
• Regulation: negative feedback (most common) and positive feedback adjust hormone levels. Receptor down‑ or up‑regulation also modulates sensitivity.

Animal (human) hormones important for growth, development and metabolism:

• Growth Hormone (GH, somatotropin) — secreted by anterior pituitary; stimulates IGF‑1 (insulin‑like growth factor) production in liver; promotes protein synthesis, cell division, bone and muscle growth. Excess in childhood → gigantism; deficiency → pituitary dwarfism; excess in adult → acromegaly.
• Thyroid hormones (T3, T4) — increase basal metabolic rate, stimulate protein synthesis and nervous system development (critical in childhood). Hypothyroidism in children → cretinism (stunted growth, mental retardation); in adults → myxedema; hyperthyroidism → weight loss, heat intolerance, nervousness.
• Insulin and Glucagon (pancreas) — key regulators of carbohydrate, lipid and protein metabolism. Insulin promotes glucose uptake and anabolic processes; glucagon promotes glycogenolysis and gluconeogenesis. Dysregulation → diabetes mellitus (type 1: insulin deficiency; type 2: insulin resistance).
• Adrenal corticosteroids (cortisol) — glucocorticoids increase gluconeogenesis, protein catabolism, and help respond to stress. Chronic excess → Cushing's syndrome; deficiency → Addison's disease.
• Sex hormones (estrogens, androgens, progesterone) — drive sexual differentiation, growth spurts at puberty, and influence bone growth and metabolism.
• Catecholamines (epinephrine, norepinephrine) — increase metabolic rate transiently during stress (fight/flight): increase heart rate, mobilize glucose and fats).

Hormonal control of developmental processes: Hormones determine timing and pattern of development. Examples include GH and thyroid hormone for body and nervous system maturation, sex steroids for pubertal changes, and cortisol for fetal lung maturation.

Plant hormones (phytohormones) regulating growth and development:

• Auxins (IAA) — promote cell elongation, apical dominance, phototropism and root initiation. High auxin at shaded side causes cell elongation and bending toward light.
• Gibberellins (GAs) — promote stem elongation, seed germination and fruit development (bolting in plants).
• Cytokinins — promote cell division, delay leaf senescence and act antagonistically with auxin in organogenesis.
• Abscisic acid (ABA) — induces seed dormancy, closes stomata during water stress, promotes cold/drought tolerance.
• Ethylene — gaseous hormone that promotes fruit ripening, leaf abscission and senescence.

Integration and cross‑talk: Growth and metabolism are controlled by interplay among hormones. Example: insulin and GH both promote growth but through different pathways; thyroid hormones increase sensitivity to catecholamines; in plants, auxin and cytokinin ratios determine root vs shoot development.

Clinical and practical relevance: Diagnosing endocrine disorders (blood hormone assays), therapeutic hormone replacement (insulin, thyroxine), use of plant hormones in agriculture (auxins for rooting, gibberellins to increase fruit size, ethylene to ripen fruit), and herbicides that mimic auxin (e.g., 2,4‑D).

Fig 16 — Educational Diagram: Regulation of Hormone Secretion

Overview

Hormone secretion is tightly regulated so the body maintains internal stability (homeostasis) and responds appropriately to changes. Regulation occurs by three main kinds of control: humoral, neural and hormonal, plus modulation by rhythms and receptor dynamics. Most control systems use negative feedback; positive feedback is used in special situations.

Main mechanisms

• Humoral regulation: Hormone release in direct response to changing blood levels of ions, nutrients or other molecules. Example: low blood Ca2+ stimulates parathyroid hormone (PTH) secretion; high blood glucose stimulates insulin.
• Neural regulation: Nerve impulses stimulate endocrine cells to release hormones (rapid). Example: sympathetic stimulation of adrenal medulla → epinephrine/norepinephrine release during stress.
• Hormonal regulation (tropic control): One endocrine gland secretes hormones that control another gland’s secretion. Example: hypothalamus releasing TRH → anterior pituitary releases TSH → thyroid releases T3/T4.

Feedback control

• Negative feedback (most common): Hormone’s effects (or end-product levels) inhibit further secretion. Example: increased T3/T4 inhibits TRH and TSH release; high blood glucose + insulin reduce further insulin requirement.
• Positive feedback (rare): Hormone action increases its own secretion until an external event stops it. Example: oxytocin during childbirth — uterine contractions → oxytocin release → stronger contractions until delivery.

Temporal patterns and modulation

• Pulsatile secretion: Many hormones are secreted in bursts (e.g., GnRH), preventing receptor desensitization and maintaining responsiveness.
• Circadian and ultradian rhythms: Daily patterns affect secretion (e.g., cortisol peaks in early morning; melatonin peaks at night).
• Receptor regulation: Up-regulation (more receptors → increased sensitivity) or down-regulation (fewer receptors → decreased sensitivity) alters tissue response to hormones. Chronic high hormone levels often cause down-regulation.
• Permissiveness, synergism and antagonism: Some hormones permit the action of others (e.g., thyroid hormones increase responsiveness to catecholamines), some act together for amplified effect (synergism), and some oppose each other (antagonism, e.g., insulin vs glucagon).

Control loop concept (simple)

Most endocrine control can be viewed as a control loop: a sensor detects a variable → an integrating center computes error relative to setpoint → endocrine gland (effector) secretes hormone → hormone alters the variable → feedback signal modifies further secretion.

Clinical and physiological relevance

• Dysregulation leads to disease: hypothyroidism (insufficient thyroid hormone), Cushing’s syndrome (excess cortisol), diabetes mellitus (impaired insulin production/action).
• Pharmacological hormones can mimic or block normal control (e.g., glucocorticoid therapy can suppress HPA axis via negative feedback).

Summary: Hormone secretion is regulated by humoral, neural and hormonal signals, fine-tuned by feedback (mostly negative), rhythmic secretion patterns and receptor dynamics to produce appropriate physiological responses.

Fig 17 — Educational Diagram: Calcium Metabolism and Bone Homeostasis

Overview: Calcium (Ca2+) is essential for skeletal structure and many physiological processes (muscle contraction, blood clotting, neurotransmission, enzyme cofactors). The body maintains plasma Ca2+ within a narrow range (~8.5–10.5 mg/dL) by coordinated actions of bone, intestine, kidney and hormones (parathyroid hormone, calcitonin, active vitamin D).

Major compartments and balance:

• About 99% of body Ca is in bone as hydroxyapatite (structural reservoir); ~1% is in extracellular fluid and soft tissues (ionized Ca2+, protein-bound, complexed).
• Calcium balance = dietary intake + bone release − (urinary excretion + fecal loss). Homeostasis adjusts bone turnover, intestinal absorption and renal excretion.

Key hormones and actions:

• Parathyroid hormone (PTH) — secreted by parathyroid glands when plasma Ca2+ falls. Effects: ↑ bone resorption (activates osteoclasts indirectly), ↑ renal reabsorption of Ca2+ (reduces urinary Ca loss), ↑ phosphate excretion (phosphaturia), and ↑ activation of vitamin D in kidney (↑ 1,25-(OH)2 vitamin D = calcitriol). Net effect: increase plasma Ca2+.
• Calcitonin — secreted by thyroid C cells when Ca2+ is high. Effects: inhibits osteoclast activity → ↓ bone resorption and lowers plasma Ca2+ (important in some species and in acute regulation).
• Vitamin D (calcitriol, 1,25-(OH)2 D3) — produced from skin (7-dehydrocholesterol → cholecalciferol) and activated in liver (25-OH D) and kidney (1,25-(OH)2 D). Effects: ↑ intestinal absorption of Ca2+ and PO4 3−, helps bone mineralization (and in some conditions supports resorption to mobilize Ca).

Bone remodeling (dynamic process):

• Remodeling cycle phases: activation → resorption (osteoclasts digest mineral & matrix) → reversal → formation (osteoblasts deposit osteoid) → mineralization.
• Osteoclasts dissolve mineral (hydroxyapatite) and degrade organic matrix; osteoblasts synthesize collagen and promote mineral deposition.
• Remodeling is regulated by mechanical stress, systemic hormones (PTH, calcitonin, vitamin D, sex steroids), and local factors (cytokines, growth factors).

Feedback control (simplified):

• Fall in plasma Ca2+ → ↑ PTH → ↑ bone resorption, ↑ renal Ca reabsorption, ↑ calcitriol production → ↑ intestinal Ca absorption → plasma Ca2+ rises → PTH secretion suppressed.
• Rise in plasma Ca2+ → ↑ calcitonin (and reduced PTH) → decreased bone resorption → plasma Ca2+ falls to set point.

Clinical relevance / disorders:

• Hypocalcemia (low Ca2+) → tetany (muscle spasms), paresthesias; causes include hypoparathyroidism, vitamin D deficiency.
• Hypercalcemia (high Ca2+) → polyuria, kidney stones, constipation, fatigue; causes include hyperparathyroidism, malignancy.
• Rickets (children) / osteomalacia (adults): defective mineralization due to vitamin D deficiency → soft bones, deformities.
• Osteoporosis: decreased bone mass and increased fracture risk from an imbalance favoring resorption over formation (age, hormonal loss, inactivity).

Integration — organs working together:

• Bone: reservoir that releases or stores Ca2+ via remodeling.
• Kidney: controls Ca2+ excretion/reabsorption and activates vitamin D (1-alpha hydroxylase stimulated by PTH).
• Intestine: site of dietary Ca2+ absorption enhanced by calcitriol.

Key points students should remember:

• PTH raises plasma Ca2+, decreases phosphate reabsorption, and stimulates calcitriol production.
• Calcitonin lowers plasma Ca2+ by inhibiting osteoclasts.
• Vitamin D increases Ca2+ (and phosphate) absorption from gut; essential for bone mineralization.
• Bone remodeling maintains bone strength and mineral homeostasis; imbalance leads to metabolic bone disease.

Fig 18 — Educational Diagram: Endocrine Disorders and Clinical Correlates

Overview
The endocrine system consists of glands that secrete hormones into the bloodstream to regulate metabolism, growth, fluid balance and reproduction. Hormones work by binding to receptors on/in target cells. Most hormone levels are regulated by negative feedback loops (e.g., hypothalamus → pituitary → peripheral gland).

Basic mechanism and clinical relevance

• Hormone excess or deficiency (or receptor resistance) produces characteristic clinical syndromes.
• Diagnosis uses history, clinical signs, biochemical tests (blood hormone levels, metabolites), imaging and stimulation/suppression tests.
• Treatment: replace deficient hormones, block excess production, treat underlying tumour/autoimmunity, metabolic control (e.g., insulin).

Major glands and principal disorders (with clinical correlates)

Pituitary gland

• Growth hormone (GH): deficiency in childhood → pituitary dwarfism (short stature); excess before epiphyseal closure → gigantism (increased height); excess after closure → acromegaly (enlarged hands, facial bones, prognathism, diabetes).
• Posterior pituitary (ADH): deficiency → diabetes insipidus (polyuria, polydipsia, low urine specific gravity); inappropriate ADH secretion (SIADH) → water retention and hyponatremia.
• Clinical tests: serum GH/IGF-1, oral glucose suppression test for acromegaly, water-deprivation test for diabetes insipidus.

Thyroid gland

• Hypothyroidism (low T3/T4): causes include Hashimoto's (autoimmune), iodine deficiency. Signs: fatigue, cold intolerance, weight gain, slowed mental development in neonates → cretinism (stunted growth, mental retardation). Adults with severe chronic hypothyroidism → myxoedema (facial puffiness, dry skin).
• Hyperthyroidism (high T3/T4): common cause Graves' disease (autoimmune). Signs: weight loss, heat intolerance, tremor, palpitations, exophthalmos (in Graves').
• Goitre: enlargement of the thyroid due to overstimulation (e.g., iodine deficiency or TSH stimulation).
• Clinical tests: serum TSH (most sensitive), free T4, T3, anti-thyroid antibodies; radioiodine uptake in hyperthyroidism.

Parathyroid glands

• Hyperparathyroidism (↑PTH): causes hypercalcemia → bone pain, kidney stones, abdominal groans, psychiatric overtones (memory problems).
• Hypoparathyroidism (↓PTH): hypocalcemia → muscle cramps, tetany, paresthesias.
• Clinical tests: serum calcium, phosphate (usually inverse to Ca), and PTH levels.

Adrenal glands

• Addison's disease (primary adrenal insufficiency): autoimmune destruction → low cortisol and aldosterone → weakness, weight loss, hyperpigmentation, hypotension, hyponatremia, hyperkalemia.
• Cushing's syndrome (excess cortisol): causes include pituitary ACTH-secreting adenoma (Cushing disease), exogenous steroids. Signs: central obesity, moon face, purple striae, muscle wasting, hyperglycemia, immunosuppression.
• Pheochromocytoma (catecholamine‑secreting tumour): episodic hypertension, headache, sweating, palpitations.
• Clinical tests: serum/urine cortisol, dexamethasone suppression test, plasma/urine catecholamines and metanephrines, ACTH levels.

Pancreas (endocrine)

• Diabetes mellitus (DM): chronic hyperglycemia from insulin deficiency (Type 1, autoimmune destruction of beta cells) or insulin resistance with relative insulin deficiency (Type 2).
• Type 1: usually childhood/young adult onset, polyuria, polydipsia, weight loss, risk of diabetic ketoacidosis.
• Type 2: associated with obesity, sedentary lifestyle; complications include neuropathy, retinopathy, nephropathy, cardiovascular disease.
• Clinical tests: fasting plasma glucose, oral glucose tolerance test (OGTT), HbA1c, urine glucose/ketones.
• Treatment: insulin (Type 1), diet/exercise and oral hypoglycemics then insulin if needed (Type 2).

Gonads and reproductive hormones

• Disorders include polycystic ovarian syndrome (PCOS): hyperandrogenism, irregular menses, insulin resistance, infertility.
• Primary amenorrhea, delayed puberty, or virilization can reflect endocrine causes (gonadal failure, pituitary or hypothalamic dysfunction).

Integration and feedback examples
Most endocrine disorders are best understood by looking at feedback patterns. Example: in primary hypothyroidism (thyroid gland failure) low T4/T3 causes high TSH (pituitary tries to compensate). In secondary hypothyroidism (pituitary failure) both TSH and T4 are low.

General diagnostic principles

• Measure hormone and downstream markers (e.g., insulin and blood glucose).
• Use stimulation or suppression tests to distinguish primary from secondary disorders.
• Imaging (ultrasound, MRI) to detect gland enlargement or tumours.

Treatment principles
Replace deficient hormone (levothyroxine for hypothyroidism, insulin for Type 1 DM, hydrocortisone for Addison's), reduce excess hormone (antithyroid drugs, surgery, radiotherapy), manage metabolic consequences (diet, antihypertensives) and treat causes (autoimmunity, tumours).

Fig 19 — Educational Diagram: Chemical Coordination in Plants

Definition and scope: Chemical coordination in plants means regulation and integration of growth, development and responses to the environment by chemical messengers called phytohormones (plant hormones) and other signalling molecules. Unlike animals, plants use a small set of hormones produced at specific sites, transported to targets, and acting at very low concentrations to change cell physiology and gene expression.

Main plant hormones (overview):

• Auxins (e.g. Indole-3-acetic acid, IAA) — synthesized mainly in shoot apices and young leaves. Functions: cell elongation, apical dominance, phototropism and gravitropism, root initiation (used in rooting powders), and inhibition of abscission.
• Gibberellins (GAs, e.g. GA3) — promote stem elongation, seed germination (break dormancy), mobilize food reserves, and stimulate flowering/bolting in some plants.
• Cytokinins (e.g. zeatin) — synthesized in roots; promote cell division, stimulate shoot formation, delay leaf senescence, and work antagonistically with auxin in organogenesis.
• Abscisic acid (ABA) — produced in mature leaves and seeds; induces seed dormancy, inhibits germination, closes stomata under water stress and mediates stress responses.
• Ethylene (C2H4) — a gaseous hormone produced in ripening fruits and stressed tissues; promotes fruit ripening, leaf abscission and senescence.
• Other regulators — brassinosteroids, jasmonates, salicylic acid and systemin (defence/signalling roles) and synthetic regulators (e.g. 2,4-D, a synthetic auxin used as herbicide).

Synthesis and transport: Hormones are synthesized in specific tissues (apices, young leaves, roots, seeds) and are transported via different routes: polar cell-to-cell transport (auxin via carrier proteins like PINs), xylem/phloem long-distance transport (cytokinins, ABA), diffusion (ethylene) or conjugation and release from inactive forms.

Mode of action / signal transduction (general steps):

• Perception: hormone binds to specific receptor (membrane or intracellular).
• Second messengers: changes in Ca2+, cGMP, IP3 or redox status may relay the signal.
• Protein phosphorylation cascade: kinases/phosphatases modify target proteins.
• Transcriptional regulation: transcription factors are activated or repressed, altering gene expression and producing long-term developmental changes.

Key physiological mechanisms (select examples):

• Auxin "acid growth" hypothesis: Auxin stimulates plasma membrane H+-ATPases → cell wall acidification → activation of expansins and wall-loosening enzymes → cell wall loosening and turgor-driven cell elongation.
• Apical dominance: High auxin from shoot apex suppresses lateral bud outgrowth; removal of apex lowers auxin and allows cytokinin action to stimulate lateral buds.
• Tropisms: Phototropism: lateral redistribution of auxin causes differential cell elongation and bending toward light. Gravitropism: auxin redistribution in roots/shoots leads to curvature (note: auxin inhibits elongation in roots but promotes it in shoots).
• Seed dormancy and germination: ABA maintains dormancy; gibberellins stimulate production of hydrolytic enzymes (e.g., alpha-amylase in cereal endosperm) to mobilize food reserves and allow germination.
• Fruit ripening: Ethylene triggers coordinated gene expression leading to softening, colour change and aroma production.

Agricultural and practical applications: rooting powders (auxins), 2,4-D as selective herbicide (synthetic auxin), gibberellins to increase stem elongation or break dormancy, ethylene or its releasers to ripen fruits, cytokinins in micropropagation for shoot induction, ABA-related treatments for stress management and seed storage.

Experimental evidence and classic experiments: Removal of coleoptile tip (Darwin) abolishes phototropic response; applied auxin restores bending. Application of gibberellin to dormant seeds triggers germination; application of ABA induces dormancy. These provide causal links between hormones and plant responses.

Summary: Chemical coordination in plants is achieved by a small set of hormones whose concentrations, sites of synthesis, transport routes and interactions (synergistic or antagonistic) regulate virtually every aspect of plant life — from cell division and elongation to stress responses, dormancy and reproduction. Understanding these hormones and their mechanisms is essential for both basic plant biology and practical crop management.

Fig 20 — Educational Diagram: Neuroendocrine Integration and Feedback Mechanisms

What it is
Neuroendocrine integration is the coordination between the nervous system and the endocrine system: specialized neurons (neurosecretory cells) convert electrical signals into hormone release, allowing the brain to control distant organs via the blood. Feedback mechanisms are regulatory loops (mainly negative feedback, sometimes positive) that keep physiological variables near a set point.

Key components and pathways

• Hypothalamus – contains neurosecretory cells that synthesise releasing/inhibiting hormones (for anterior pituitary) and neurohormones (oxytocin, ADH) transported to the posterior pituitary.
• Hypophyseal (pituitary) system – anterior pituitary secretes trophic hormones (TSH, ACTH, LH, FSH, GH, prolactin) under hypothalamic control via the hypophyseal portal vessels; posterior pituitary releases hypothalamic neurohormones (ADH, oxytocin) directly into blood.
• Neuroendocrine cell action – neuronal input (sensory, circadian, stress) → action potentials in neurosecretory cells → hormone exocytosis into circulation → target tissues respond via receptors.

Feedback mechanisms

• Negative feedback – increased level/effect of a hormone inhibits its further release (primary homeostatic mechanism). Example: high thyroid hormones (T3/T4) suppress TRH and TSH release; high cortisol suppresses CRH and ACTH (long-loop).
• Short-loop feedback – pituitary hormones inhibit hypothalamic releasing hormones (e.g., ACTH inhibiting CRH).
• Positive feedback – hormone effect amplifies its own production until an event completes (less common). Example: oxytocin during childbirth increases uterine contractions, which stimulate more oxytocin release (birth ends the loop).
• Pulsatile and circadian secretion – some neuroendocrine signals are released in pulses (GnRH → LH/FSH pulses) or show daily rhythms (cortisol peaks in early morning).

Functional significance
Neuroendocrine integration allows rapid sensing (neurons) with sustained, body-wide responses (hormones). Feedback loops provide stability (homeostasis), allow graded responses, prevent hormone overproduction, and create time-structured signalling (pulses, rhythms).

Illustrative sequence: HPA axis (stress)
Stress → hypothalamus releases CRH → anterior pituitary releases ACTH → adrenal cortex secretes cortisol. Rising cortisol then suppresses CRH and ACTH (negative feedback). This axis exemplifies neuroendocrine integration and feedback.

Fig 21 — Educational Diagram: Plant Tropisms and Responses

Definition: Tropisms are directional growth responses of plants in which the direction of the stimulus determines the direction of growth (towards = positive, away = negative). Plant responses also include non-directional movements (nastic movements) and rapid turgor-driven responses.

Major types of tropisms:

• Phototropism – growth response to light. Shoots typically show positive phototropism (bend towards light); mediated mainly by blue-light photoreceptors (phototropins).
• Gravitropism (Geotropism) – response to gravity. Roots show positive gravitropism (grow downward); shoots show negative gravitropism (grow upward). Gravity sensing involves statoliths (starch grains) in columella cells.
• Hydrotropism – growth toward moisture (roots growing to higher water potential).
• Thigmotropism – growth response to touch/contact (e.g., tendrils coiling around supports).
• Chemotropism – growth response to chemicals (e.g., pollen tube growth toward ovule signals).
• Thermotropism – response to temperature gradients (less common).

Mechanism (general):

• Tropisms are achieved by differential cell elongation on opposite sides of an organ. The side with faster cell elongation becomes the convex side, causing bending.
• Cholodny–Went hypothesis: Asymmetric distribution of the plant hormone auxin (IAA) causes differential growth. A stimulus redistributes auxin to one side; in shoots, higher auxin concentration promotes cell elongation on the shaded side (causing bending toward light). In roots, high auxin inhibits elongation, so redistribution produces opposite bending.
• Acid growth hypothesis: Auxin stimulates H+-ATPases in the plasma membrane, lowering apoplastic pH. Acidification activates expansins and cell-wall loosening enzymes → cell-wall extensibility increases and cells elongate when turgor is maintained.

Key experimental evidence:

• Darwin’s coleoptile experiments: tip senses light; bending requires an intact tip.
• Boysen-Jensen: separation of tip from the growing region by a permeable barrier allowed bending (chemical signal diffusion), impermeable barrier prevented bending.
• Went’s agar block experiment: agar placed on shaded side of coleoptile tip acquired a substance (auxin) that caused bending when applied to decapitated coleoptiles.

Hormonal control & differences:

• Auxins (IAA) — central in tropisms: redistribute asymmetrically to cause differential growth. Promote elongation in shoots, inhibit elongation in roots (dose- and tissue-dependent).
• Other hormones: Cytokinins (cell division, interaction with auxin in organogenesis), gibberellins (stem elongation), ethylene (inhibits elongation, promotes triple response and can mediate touch responses), abscisic acid (stress responses), and peptides/other signals in tropic contexts.
• Photoreceptors: Phototropins (blue light) mediate phototropism; phytochromes (red/far-red) mediate other light responses like shade avoidance and germination.

Nastic movements and rapid responses (contrast with tropisms): Nastic movements are non-directional responses dependent on the structure, not stimulus direction. Examples: nyctinasty (leaf folding in legumes at night), thigmonasty (Mimosa pudica leaf folding on touch), rapid trap closure in Dionaea (Venus flytrap) caused by action potentials and rapid turgor changes.

Physiological basis of rapid movements: Rapid movements often depend on fast changes in cell turgor driven by ion fluxes (K+, Cl–) across membranes, producing water movement and rapid volume changes in motor cells (e.g., pulvini in legumes). Electrical signals (action potentials) can coordinate these changes.

Summary: Tropisms are directional growth responses mainly controlled by asymmetric auxin distribution and differential cell elongation. They allow plants to orient shoots toward light and roots toward water and minerals. Nastic and rapid turgor-mediated movements complement growth-mediated tropisms for behavior and protection.

Fig 22 — Educational Diagram: Comparative and Minor Endocrine Organs

Overview
In addition to the principal endocrine glands (pituitary, thyroid, adrenal, pancreas, gonads), many organs have secondary or minor endocrine functions. These organs secrete hormones or hormonelike factors that help regulate local and systemic physiology. Comparative endocrinology examines how endocrine structures and hormones vary across animal groups (vertebrates vs invertebrates) and how analogous systems accomplish similar regulatory tasks.

Minor endocrine organs and their major secretions (with functions)

• Heart: Atrial natriuretic peptide (ANP/ANF) — reduces blood volume and blood pressure by increasing sodium and water excretion and by inhibiting renin–angiotensin secretion.
• Kidney: Erythropoietin (EPO) — stimulates red blood cell production; also converts vitamin D to its active form (calcitriol) and releases renin (RAAS activation for blood pressure).
• Liver: Angiotensinogen (RAAS precursor), insulin-like growth factors (IGFs) — mediate growth effects of GH; thrombopoietin — regulates platelet production.
• Gastrointestinal tract: Enteric hormones (gastrin, secretin, cholecystokinin, GIP) — regulate digestion, enzyme secretion and motility.
• Adipose tissue: Leptin, adiponectin, resistin — regulate appetite, energy balance and insulin sensitivity.
• Pineal gland: Melatonin — controls circadian rhythms and reproductive seasonality in some animals.
• Thymus: Thymosins and thymopoietin — involved in T‑cell maturation and immune system development.
• Skin: Precursor conversion of 7‑dehydrocholesterol to cholecalciferol (vitamin D3) under UV; active vitamin D regulates calcium metabolism.
• Placenta (in mammals): hCG, progesterone, estrogen, human placental lactogen — maintain pregnancy and modify maternal metabolism.

Comparative aspects (vertebrates vs invertebrates)

• Vertebrates: Well‑differentiated endocrine glands (thyroid, adrenals, pituitary). Many organs (heart, kidney, liver) have clear endocrine roles as above. Fish have additional specific structures (e.g., corpuscles of Stannius in teleosts producing stanniocalcin for calcium homeostasis).
• Invertebrates (especially insects): Endocrine control is mainly neuroendocrine. Key glands include the prothoracic glands (produce ecdysteroids/ecdysone for moulting), corpora allata (produce juvenile hormone (JH) that determines larval vs adult development), and the corpora cardiaca (store/release neurohormones). Hormonal coordination is crucial for metamorphosis and diapause.

Physiological significance and clinical relevance
Minor endocrine organs provide rapid and fine tuning of homeostasis. Clinical examples: decreased EPO → anemia of chronic disease; altered ANP/renin → hypertension; leptin resistance → obesity; vitamin D deficiency → rickets/osteomalacia; placental hCG → basis of pregnancy tests.

Integration and feedback
Minor endocrine hormones often act within feedback loops or synergize with major endocrine axes (e.g., liver IGFs mediate effects of pituitary GH; kidney renin activates angiotensin II which interacts with adrenal aldosterone and cardiac ANP). Understanding these interactions is essential for physiology and medicine.

Note: Diagrams that compare hormone sources across organs and graphs of hormone levels over time (circadian, developmental or dose–response) are especially useful for visual learning.

Fig 23 — Educational Diagram: Practical and Experimental Aspects

Overview
Practical and experimental aspects of Chemical Coordination and Integration cover laboratory methods and simple investigations used to demonstrate how hormones and chemical regulators work in animals and plants, how to measure their effects, and how to interpret data. Emphasis is on designing controlled experiments, collecting quantitative data, plotting results, understanding dose–response relationships, and appreciating safety and ethical constraints.

Common objectives of experiments

• Demonstrate physiological effects of hormones (e.g., change in heart rate, blood glucose, growth, or tropic responses).
• Show dose–response relationships and determine relative potency.
• Compare treated vs control samples and calculate percentage change or rates.
• Observe feedback patterns (e.g., hormone secretion vs blood parameter) and explain integration.

Typical experimental approaches (animal systems)

• Daphnia or small invertebrates to study cardioactive agents: measure heart rate (beats per minute) before and after adding graded concentrations of adrenaline, caffeine or acetylcholine. Advantages: visible heart, minimal ethical issues.
• Non-invasive human practicals: measure blood glucose (using glucometer/strips) before and after a standard glucose drink to demonstrate insulin action (requires consent and safety precautions). Record glucose vs time.
• Isolated tissue preparations (demonstration level in guided labs): frog/embryonic heart or cardiac strip perfusion to show effect of sympathetic/parasympathetic agents — usually demonstrated by teacher in proper labs with ethics compliance.

Typical experimental approaches (plant systems)

• Phototropism or geotropism experiments: decapitate or cover coleoptile tips and expose to unilateral light; measure curvature over time to infer role of auxins.
• Auxin/Agar block assay (Avena test style): apply auxin to one side of a coleoptile or use agar blocks soaked in IAA to induce elongation and bending.
• Seed germination/growth bioassays: apply gibberellic acid (GA) to seeds or plants and measure stem elongation vs controls.
• Ethylene treatments: demonstrate accelerated fruit ripening (banana/apple/green tomato) by exposing fruits to ethylene or ethylene-generating conditions.

Experimental design and data handling

• Always include controls (untreated) and replicate samples (biological and technical replicates).
• Independent variable: hormone/chemical concentration or time; dependent variable: physiological response (heart rate, curvature angle, glucose level, growth length).
• Record raw data, compute derived values (percentage change, rate, mean ± SD) and plot appropriate graphs (dose–response, time-course).
• Use simple statistics: mean, standard deviation, and, where required, % change = ((final - initial)/initial)*100.

Safety and ethical considerations

• Prefer invertebrate models (Daphnia) or plant systems for class practicums. For human measurements, obtain consent and follow safety rules; avoid exposing students to harmful chemicals or animal harm.
• Dispose of chemical and biological waste as per school guidelines.

Interpretation: integration and feedback
Use experiments to relate observed effects to endocrine principles: hormone specificity (receptors), dose dependency, second-messenger mediated amplification (e.g., cAMP), and negative/positive feedback control (e.g., insulin–glucagon axis, hypothalamo–pituitary axes).

Fig 24 — Educational Diagram: Integration and Homeostasis

Integration and homeostasis describe how organisms detect internal and external changes, coordinate responses through nervous and endocrine systems (integration), and maintain stable internal conditions (homeostasis). Homeostasis is dynamic equilibrium around a set point (e.g., 37°C for human core temperature, ~5 mM blood glucose fasting).

Key components of a homeostatic control system:

• Sensor (receptor): detects deviation in a variable (temperature receptors, glucose sensors).
• Integrator (control centre): compares the signal with a set point and decides response (hypothalamus, pancreatic islets).
• Effector: carries out corrective action (sweat glands, blood vessels, liver, muscles, kidneys).

Types of integration:

• Nervous integration: fast, short-lived responses using nerves and neurotransmitters (withdrawal reflex, rapid vasodilation).
• Endocrine (chemical) integration: slower, longer-lasting control by hormones (insulin, ADH, thyroid hormones).

Feedback mechanisms:

• Negative feedback: the most common mechanism. A deviation from set point triggers responses that reduce the deviation (e.g., high blood glucose → insulin release → glucose uptake → blood glucose falls). Negative feedback maintains stability.
• Positive feedback: amplifies a change until an end condition is reached (e.g., oxytocin-mediated uterine contractions during childbirth; blood clotting cascade). Positive feedback is less common and usually self-limiting by an external event.

Examples of homeostatic systems include thermoregulation (sweating, shivering, vasodilation/constriction), blood glucose regulation (insulin and glucagon), osmotic balance and water regulation (ADH and kidney), calcium balance (PTH and calcitonin), and acid–base balance (respiratory and renal compensation).

When integration fails: loss of homeostatic control causes disease — e.g., diabetes mellitus (impaired insulin signalling → hyperglycaemia), dehydration from ADH deficiency, hyper/hypothyroidism affecting metabolic rate.

Takeaway: Integration (coordinated signalling by nerves and hormones) enables effectors to restore internal variables to set points via feedback control, keeping the internal environment stable despite external changes.

Fig 25 — Educational Diagram: Plant Hormones and Chemical Coordination in Plants

Overview: Plants coordinate growth, development and responses to the environment using chemical messengers called plant hormones (phytohormones). Unlike animal hormones, small amounts act locally or systemically, often through changes in gene expression, ion fluxes and second messengers (Ca2+, cyclic GMP, IP3).

Major plant hormones, sites of synthesis and main roles

• Auxins (e.g., IAA) — synthesized mainly in shoot apical meristems, young leaves and developing seeds. Promote cell elongation (acid-growth hypothesis), apical dominance, vascular differentiation and root initiation. Polar transport (basipetal) via PIN and AUX/LAX proteins creates gradients that direct tropic responses (phototropism, gravitropism).
• Gibberellins (GAs) — produced in young leaves, embryos, and growing tissues. Promote stem elongation, seed germination (stimulate α-amylase in aleurone), and flowering in some plants. Deficiency gives dwarfism; excess causes tall, spindly growth.
• Cytokinins — synthesized in root tips and transported upward. Promote cell division, delay leaf senescence, stimulate shoot formation and affect nutrient mobilization. Action often depends on auxin:cytokinin ratio.
• Abscisic acid (ABA) — synthesized in mature leaves, roots and seeds. Promotes stomatal closure (drought response), induces seed dormancy and inhibits growth. ABA levels increase under stress.
• Ethylene (gaseous) — produced in ripening fruits, senescing tissues and stressed tissues. Promotes fruit ripening, leaf abscission, and triple response in seedlings; interacts with auxin and ABA in abscission and senescence.
• Brassinosteroids — ubiquitous, promote cell expansion and vascular differentiation; similar to steroid hormones in animals (but plant-specific).
• Jasmonates and Salicylic Acid — important in defense signalling (wounding, pathogen resistance) and in reproductive development.
• Florigen (FT protein) — a mobile protein signal from leaves that induces flowering (not a classical small-molecule hormone).

Mechanisms of action

• Perception by specific receptors (membrane or nuclear). Example: many auxin effects involve the TIR1/AFB receptor that targets Aux/IAA repressors for degradation, freeing ARF transcription factors.
• Second messengers (Ca2+, IP3, cGMP) rapidly alter ion channels, enzyme activity and cytoskeleton for quick responses (stomatal movement, tropisms).
• Longer-term effects via changes in gene transcription and protein synthesis (e.g., GA-induced α-amylase in seeds).

Interactions and balance: Plant responses depend on hormone ratios, not single hormones alone (e.g., apical dominance is maintained by high auxin from the shoot apex and low cytokinin in axillary buds; removing the apex lowers auxin and allows cytokinin-driven bud outgrowth). Hormones can be synergistic or antagonistic.

Tropic and nastic movements

• Phototropism: Blue light perceived by phototropins causes asymmetric auxin redistribution; more auxin on shaded side induces cell elongation and bending toward light.
• Gravitropism: Statoliths (amyloplasts) in root cap and coleoptile cells orient auxin flow; in roots high auxin on lower side inhibits elongation (root bends down), while in shoots it promotes elongation (shoot bends up).
• Nastic movements: Rapid movements (e.g., Mimosa pudica folding) mediated by ion fluxes and turgor changes under neuronal-like electrical signalling and chemical mediators.

Chemical coordination vs. nervous coordination: Plants lack nervous systems; instead they use hormones and mobile proteins to transmit information slowly (minutes to days) for developmental coordination, plus fast electrical and hydraulic signals for rapid local responses.

Applications / Practical significance: Synthetic hormones and inhibitors are used in agriculture — rooting powders (IBA, NAA), gibberellins to increase fruit size or break dormancy, ethylene to ripen climacteric fruits, 2,4-D as a selective herbicide, cytokinins to delay senescence.

Summary: Plant hormones are small amounts of chemical regulators produced at specific sites; they act alone or in combination to regulate virtually every aspect of plant life through complex signalling pathways and cross-talk.

Fig 26 — Educational Diagram: Plant Responses to Stimuli

Overview
Plants perceive external and internal stimuli and respond by directional growth (tropisms), non-directional movements (nastic movements), or physiological changes via chemical regulators (plant hormones). Responses help plants optimize light capture, water/nutrient acquisition, reproduction and survival.

Main categories

• Tropisms – directional growth responses toward or away from a stimulus. Named after stimulus: phototropism (light), geotropism/gravitropism (gravity), hydrotropism (water), chemotropism (chemicals), thigmotropism (touch).
• Nastic movements – non-directional movements dependent on stimulus intensity, not direction (e.g., nyctinasty, seismonasty). Examples: opening/closing of flowers, Mimosa pudica folding on touch.
• Physiological/chemical responses – stomatal movements, abscission, fruit ripening, dormancy and flowering regulated by hormones (auxins, gibberellins, cytokinins, ethylene, abscisic acid) and signaling molecules.

Mechanism of most growth responses
Many directional responses are produced by unequal cell elongation on opposite sides of an organ. Auxin (indole-3-acetic acid, IAA) redistribution is central: e.g., unilateral light causes IAA to migrate to shaded side of coleoptile/shoot, increasing cell elongation there and causing curvature toward light.

Classic experiments

• Darwin: coleoptile tip required for phototropic response.
• Boysen-Jensen: demonstrated a mobile chemical diffuses from tip (blocked by impermeable barriers but not by gelatin).
• Went: quantified auxin activity with agar blocks — foundation for auxin concept.

Examples of hormonal control
Abscisic acid (ABA) promotes stomatal closure & seed dormancy; ethylene promotes fruit ripening and leaf abscission; cytokinins promote cell division; gibberellins promote stem elongation and seed germination; auxins regulate cell elongation, apical dominance and tropisms.

Adaptive significance
Tropisms and nastic movements orient photosynthetic organs, anchor roots, guide pollen tubes to ovules (chemotropism), and enable rapid defensive movements or closing of stomata under stress.

Practical notes for students
When describing a tropic response, state stimulus, organ, direction (+ or –), and mechanism (hormone redistribution → differential growth). For nastic movements, state stimulus intensity and reversible/rapid nature where applicable.

Fig 27 — Educational Diagram: Interactions Between Hormones

Definition: Hormonal interactions describe how two or more hormones acting together influence a physiological process. Interactions modify magnitude, direction or quality of the response compared to individual hormone actions.

Why interactions matter: Most physiological events require coordinated action of several hormones (growth, metabolism, reproduction, stress response). Interactions allow fine regulation, integration of signals and appropriate homeostatic responses.

Major types of interactions

• Synergistic (additive/ potentiation): Two hormones produce a greater combined effect than the sum of their separate effects. Mechanisms include converging second-messenger pathways or simultaneous activation of complementary steps in a pathway.
• Permissive: Hormone A is required for full effect of hormone B. Alone A may have little effect, but it enables or increases the responsiveness of the target tissue to B (often by increasing receptor number or signalling components).
• Antagonistic: One hormone opposes the action of another. Antagonism may be direct (opposite physiological effect) or indirect (reducing receptors or downstream signalling of the other hormone).
• Complementary/Integrative: Different hormones act on different target cells or steps to produce a single coordinated outcome (often discussed as part of synergism in textbooks).

Mechanisms of interaction (brief):

• Receptor regulation: up- or down-regulation of hormone receptors (e.g., thyroid hormone increases β-adrenergic receptor expression).
• Second-messenger cross-talk: hormones using same (e.g., cAMP) or interacting signalling cascades can potentiate or inhibit each other.
• Enzyme synthesis: one hormone induces synthesis of enzymes or transporters required for another hormone's action.
• Opposing metabolic pathways: opposing enzymes or transport processes mediate antagonism (e.g., glycogen synthesis vs breakdown).

Physiological and clinical relevance: Understanding interactions explains complex responses — e.g., stress response (glucagon, epinephrine, cortisol), growth (GH needs thyroid hormones and insulin), and guides therapy (combination hormone replacement or blocking agents).

Summary: Hormonal interactions are essential for integrated body functions. Recognizing whether hormones act synergistically, permissively, or antagonistically helps predict net physiological effects and design treatments.

Fig 28 — Educational Diagram: Techniques, Assays and Practical Applications

Overview
"Techniques, Assays and Practical Applications" covers methods used to detect, quantify and localize hormones and signalling molecules and how these methods are applied in medicine, agriculture and research. Assays can be biological (bioassays) or analytical (immunoassays, chromatographic and spectrophotometric methods). The results are interpreted using calibration curves and basic concentration/dilution calculations.

Main techniques — concise descriptions

• Bioassays: Use a living tissue/organism response as a measure of hormone activity. Example: Avena (oat) coleoptile curvature bioassay for auxin — angle of curvature vs auxin concentration (dose–response).
• Immunoassays (use antibodies):
  • Radioimmunoassay (RIA): uses radioactive labelled antigen and antibody competition to quantify hormones (historically important for very low concentrations).
  • ELISA (enzyme-linked immunosorbent assay): enzyme label produces a coloured product; absorbance is read and compared to standards — widely used in clinical and lab tests (e.g., pregnancy tests, insulin assays).
• Chromatography: separates components for identification/quantitation. Types: paper/column, thin-layer chromatography (TLC), gas chromatography (GC) and high performance liquid chromatography (HPLC). Often coupled with mass spectrometry (GC–MS, LC–MS) for precise identification.
• Spectrophotometry and fluorometry: measure light absorbance or fluorescence of a reaction product. Used for enzyme assays and ELISA readouts (Beer–Lambert law applies).
• Receptor-binding and radioligand assays: measure binding of labelled ligand/hormone to receptors to estimate receptor number or ligand concentration.
• Immunolocalization / Immunohistochemistry: localize hormones or signalling proteins in tissues using labelled antibodies (colour or fluorescence microscopy).

How assays are interpreted
Most quantitative assays produce a measurable signal (angle, optical density, counts per minute, peak area). A standard (calibration) curve using known concentrations is prepared; the sample signal is matched to the curve to find concentration. Proper controls and dilutions are essential.

Key practical considerations

• Specificity: antibody/technique should discriminate the hormone from similar molecules.
• Sensitivity: lowest detectable concentration (important for hormones present at pico- to nanomolar levels).
• Accuracy and precision: use replicates, blanks and standards.
• Sample preparation: removal of interfering substances, extraction and purification (often by chromatography).

Practical applications — summary
Diagnosis of endocrine disorders, pregnancy testing, monitoring therapeutic drugs (e.g., insulin), agricultural use of plant growth regulators, environmental monitoring of endocrine-disrupting chemicals, and basic research into hormone action and localization.

Fig 29 — Educational Diagram: Key Terms and Concepts

Overview: Chemical coordination and integration in animals is controlled mainly by hormones — chemical messengers secreted by endocrine glands — and by the nervous system. Hormones act on specific target cells to regulate metabolism, growth, reproduction and homeostasis. Key concepts include kinds of hormones, modes of action, major endocrine glands and axes, feedback regulation, and examples of physiological control.

• Endocrine vs Exocrine glands: Endocrine glands (e.g., thyroid, adrenal, pituitary) secrete hormones directly into blood; exocrine glands (e.g., salivary, sweat, pancreas acinar cells) release secretions via ducts.
• Hormone: A chemical messenger produced in minute amounts, transported in blood, acting on distant target cells that bear specific receptors. Types: peptide/protein, steroid, and amino-acid derived (amine) hormones.
• Target cell and receptor: Hormones act only on cells with specific receptors. Receptors may be membrane-bound (peptide/amine hormones) or intracellular (steroid and thyroid hormones).
• Mode of action:
  • Peptide/amine hormones: bind membrane receptors → activate second messengers (e.g., cAMP, IP3/DAG) → rapid changes in enzyme activity or ion flux.
  • Steroid/thyroid hormones: diffuse into cells, bind intracellular receptors → hormone–receptor complex alters gene transcription → slower but longer-lasting effects.
• Second messenger (cAMP) pathway: A common signalling route where hormone binding activates a G protein, stimulating adenylate cyclase to convert ATP to cAMP, which activates protein kinase A and leads to cellular response.
• Hypothalamo–hypophyseal (pituitary) axis: The hypothalamus controls the pituitary. Anterior pituitary (adenohypophysis) secretes GH, TSH, ACTH, FSH, LH, PRL (tropic and non-tropic). Posterior pituitary (neurohypophysis) stores and releases neurohormones (ADH/vasopressin and oxytocin) produced in hypothalamic neurons.
• Feedback regulation:
  • Negative feedback: most common — end product inhibits upstream secretion (e.g., high T3/T4 suppress TRH/TSH).
  • Positive feedback: amplifying loop seen in e.g., oxytocin during labour (cervical stretch → oxytocin → stronger contractions → more stretch).
• Hormone interactions:
  • Synergistic: combined effect > sum of individual effects (e.g., FSH + estrogen on follicle development).
  • Permissive: one hormone enables another to act (e.g., thyroid hormones increase responsiveness to epinephrine).
  • Antagonistic: hormones with opposite effects (e.g., insulin vs glucagon on blood glucose).
• Neurohormones and neuroendocrine integration: Some neurons secrete hormones (neurohormones) into blood — e.g., ADH, oxytocin, releasing/inhibiting factors from hypothalamus — linking nervous and endocrine systems.
• Half-life and clearance: Hormones have characteristic half-lives (time for concentration to fall by half). Short half-life → rapid onset/offset; long half-life → prolonged action. Half-life affects dosing in therapeutics.
• Major glands and representative hormones:
  • Hypothalamus: TRH, CRH, GnRH, GHRH, somatostatin (regulators)
  • Pituitary: GH, TSH, ACTH, FSH, LH, PRL, ADH, oxytocin
  • Thyroid: T3, T4 (metabolism), calcitonin (lowers blood Ca2+)
  • Parathyroid: PTH (raises blood Ca2+)
  • Adrenal cortex: cortisol (glucose metabolism, stress), aldosterone (Na+/K+ balance)
  • Adrenal medulla: epinephrine/norepinephrine (fight-or-flight)
  • Pancreatic islets: insulin (lowers blood glucose), glucagon (raises blood glucose)
  • Gonads: estrogen, progesterone, testosterone (reproduction)
  • Pineal: melatonin (circadian rhythms)
• Common endocrine disorders:
  • Diabetes mellitus (insulin deficiency/resistance) — hyperglycaemia.
  • Diabetes insipidus (ADH deficiency or receptor defect) — polyuria, dilute urine.
  • Hypothyroidism (low T3/T4) — fatigue, weight gain; hyperthyroidism (high T3/T4) — weight loss, heat intolerance.
  • Cushing’s syndrome (excess cortisol) and Addison’s disease (cortisol deficiency).
  • Gigantism/acromegaly (GH excess) and dwarfism (GH deficiency).
• Clinical and physiological relevance: Hormones are used therapeutically (insulin, thyroxine, corticosteroids, contraceptive steroids). Understanding feedback and receptor action is essential for diagnosis and treatment of endocrine diseases.

Tip: Focus on how hormones are produced, how they reach and act on target cells, and how feedback loops maintain homeostasis. Memorise major glands, hormone names and principal effects (e.g., insulin lowers blood glucose; glucagon raises it).